Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Treatment Regimens for Visceral Leishmaniasis
NCT00523965Phase 3Completed
- Sponsor
- Banaras Hindu University
- Start
- Sep 2007
- Primary completion
- Aug 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b, miltefosine, paromomycin in visceral leishmaniasis (VL), sponsored by Banaras Hindu University. Started Sep 2007; status: completed.
02
Drugs
amphotericin bmiltefosineparomomycin
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on NCT00523965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523965.